Biomerica share price logo

Biomerica

NASDAQ: BMRA

$2.32

-0.14

(-5.69%)

as on

Biomerica Stock Performance

as on September 26, 2026 at 2:16 pm IST

  • Day's Low

    Day's High

    $2.18
    $2.64
    downward going graph

    6.03%

    Downside

    13.79%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $1.45
    $3.21
    downward going graph

    37.50%

    Downside

    38.50%

    Upside

    downward going graph

Biomerica share price movements today

Previous Close
$2.46
Open
$2.43
Volume
1.0M
Market Cap
$11.3M
Day's Low - High
$2.18 - $2.64
52 Week Low - High
$1.45 - $3.21

Biomerica Historical Returns

1 Month Return
+ 37.29 %
3 Month Return
+ 32.57 %
1 Year Return
-17.44 %
3 Year Return
-68.49 %
5 Year Return
-94.35 %

Biomerica Stock Fundamentals & Key Indicators

Check Biomerica market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$11.3M

EPS (TTM)

-1.26

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-1.96

Industry PE ratio

-3.42

PEG Ratio

0.01678042629754726

EBITDA

-3.7M

Revenue (TTM)

4.5M

Profit Margin

8.09%

Return On Equity TTM

-97.19%

Biomerica Stock Valuation

Track how Biomerica P/E has moved over time to understand its valuation trends.

Biomerica in the last 5 years

  • Overview

  • Trends

Lowest (-78.32x)

May 31, 2022

Industry (-3.42x)

May 31, 2026

Today (-1.82x)

May 31, 2026

Highest (-1.41x)

May 31, 2025

LowHigh

Today’s Price to Earnings Ratio: -1.82x

Biomerica vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Biomerica with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Buy$11.3M-94.35%-1.968.09%0.00%
Buy$49.4B-28.13%49.2777.98%0.00%
Buy$116.1B-31.83%21.6466.69%3.19%
StrongBuy$179.4B-18.56%32.556.80%2.40%
StrongBuy$105.5B-1.55%27.7265.17%1.27%

Stock Returns calculator for Biomerica Stock including INR - Dollar returns

The Biomerica stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Biomerica investment value today

Current value as on today

₹89,213

Returns

-₹10,787

(-10.79%)

Returns from Biomerica Stock

-₹17,438 (-17.44%)

Dollar Impact

₹6,650 (+6.65%)

Analyst Recommendation on Biomerica Stock

Based on 7 analysts

BUY

85.71%

Buy

14.29%

Hold

0.00%

Sell

Based on 7 analysts, 85.71% of analysts recommend a 'BUY' rating for Biomerica. Average target price of $13

Biomerica Share Price Target

Get share price movements and forecasts by analysts on Biomerica.

What analysts predicted

82.15%UPSIDE

Target Price

$13

Current Price

$2.32

Analyzed by

7 Analysts

Target

$13.00

Biomerica target price $13, a slight upside of 82.15% compared to current price of $2.32. According to 7 analysts rating.

Indian Investors' Interest in Biomerica Stock

Search interest for Biomerica Stock has increased by 35% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:35% versus previous 30 day period

Biomerica Quarterly Profit & Loss

All numbers in Millions USD

Feb 2024
May 2024
Aug 2024
Nov 2024
Feb 2025
May 2025
Aug 2025
Nov 2025
Feb 2026
May 2026
Total Revenue
1
1
1
1
1
0
1
1
0
0
Gross Profit
0
0
0
0
0
0
0
0
0
0
Operating Income
-2
-1
-1
0
-1
-1
-1
-1
-1
-1
EBITDA
-1
-1
-1
0
-1
-1
0
-1
-1
-1
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-1
-1
-1
0
-1
-1
0
-1
-1
-1
Income Tax Expense
0
0
0
0
0
0
0
0
0
0
Net Income
-1
-1
-1
0
-1
-1
0
-1
-1
-1
Net Profit Margin
-14.65%
1.79%
15.99%
26.71%
1.70%
-32.58%
30.72%
4.21%
-4.46%
-8.11%

Biomerica Annual Profit & Loss

All numbers in Millions USD

May 2017
May 2018
May 2019
Aug 2020
May 2021
May 2022
May 2023
May 2024
May 2025
May 2026
Total Revenue
5
5
5
6
7
18
5
5
5
4
Gross Profit
2
1
1
1
0
2
0
0
0
0
Operating Income
0
-1
-2
-2
-7
-4
-7
-6
-5
-5
EBITDA
0
-1
-2
-1
-7
-3
-6
-5
-4
-4
Interest Expense
0
0
0
0
0
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
0
-1
-2
-2
-7
-4
-7
-5
-4
-3
Income Tax Expense
-
0
0
0
0
0
0
0
0
0
Net Income
0
-1
-2
-2
-7
-4
-7
-5
-4
-3
Net Profit Margin
34.91%
31.53%
24.84%
26.62%
5.09%
15.78%
8.35%
11.28%
9.38%
8.13%

Biomerica Quarterly Cash Flow

All numbers in Millions USD

Feb 2024
May 2024
Aug 2024
Nov 2024
Feb 2025
May 2025
Aug 2025
Nov 2025
Feb 2026
May 2026
Net Income
-1
-1
-1
0
-1
-1
0
-1
-1
-1
Operating Cash Flow
-1
-1
-1
0
-1
0
0
0
-1
0
Investing Cash Flow
0
0
0
0
0
0
0
0
0
0
Financing Cash Flow
-
0
0
0
1
0
0
0
0
0
Change in Cash
-1
-1
-1
0
0
0
0
0
-1
0

Biomerica Annual Cash Flow

All numbers in Millions USD

May 2017
May 2018
May 2019
Aug 2020
May 2021
May 2022
May 2023
May 2024
May 2025
May 2026
Net Income
0
-1
-2
-2
-7
-4
-7
-5
-4
-3
Operating Cash Flow
0
-1
-2
-4
-5
0
-5
-5
-3
-3
Investing Cash Flow
0
0
0
0
0
0
0
0
0
0
Financing Cash Flow
0
1
1
12
1
2
9
0
2
2
Change in Cash
0
0
0
7
-4
1
3
-5
-1
-1

Mutual Funds that own Biomerica Stock

Check out the Mutual Funds with significant holdings in Biomerica.

Funds
Holdings
Shares Held
USAA Mutual Funds Trust
2.244164%
102984
Perritt Funds Inc
1.525397%
70000
Fidelity Concord Street Trust
0.370715%
17012
VANGUARD INDEX FUNDS
0.31628%
14514
Victory Portfolios III
0.029941%
1374

Global Institutional Holdings in Biomerica

Funds
Holdings
USAA Mutual Funds Trust
2.24%
Perritt Funds Inc
1.53%
Fidelity Concord Street Trust
0.37%
VANGUARD INDEX FUNDS
0.32%
Vanguard
0.32%

Insights on Biomerica

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 month, BMRA stock has moved up by 10.5%

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 3 quarters, -1.32M → -1.14M (in $), with an average increase of 7.6% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Edwards Lifesciences Corp has given 13.2% return, outperforming this stock by 30.6%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Edwards Lifesciences Corp has given 23.1% return, outperforming this stock by 90.9%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 4 quarters, 1.38M → 875.0K (in $), with an average decrease of 14.0% per quarter

About Biomerica

Biomerica, Inc. is a biomedical technology firm that invents, secures intellectual property for, produces, and globally distributes diagnostic and therapeutic solutions aimed at identifying and addressing a range of medical conditions and diseases. The company's diagnostic testing kits analyze patient samples, such as blood, urine, or stool, to pinpoint various illnesses and health complications. These kits are also capable of quantifying minute concentrations of specific substances like bacteria, hormones, antibodies, antigens, or other compounds present in bodily fluids or waste. Biomerica primarily sells its products for gastrointestinal disorders, food sensitivities, diabetes, and a variety of specialized diagnostic evaluations. Its distribution channels include physicians' clinics, retail pharmacies, and hospital/clinical laboratories. The company is currently developing InFoods, a diagnostic-guided therapy technology for irritable bowel syndrome; products for Helicobacter pylori; and comprehensive diagnostic tools for COVID-19, encompassing their development, testing, validation, and sale. Established in 1971, Biomerica, Inc. maintains its corporate headquarters in Irvine, California.
OrganisationBiomerica
Headquarters17571 Von Karman Avenue, Irvine, CA, 92614, US
IndustryMedical - Devices
CEOZackary S. Irani
E-voting on sharesClick here to vote

Key Management of Biomerica

Name

Title

Mr. Zackary S. Irani

CEO & Director

Mr. Allen C. Barbieri

Executive Vice-Chairman of the Board & Corporate Secretary

Ms. Lucy Liu Ph.D.

Director of Manufacturing & Technical Operations

Mr. Scott Madel

Chief Commercial Officer

FAQs

What is Biomerica share price today?

Biomerica share price today is $2.32 as on at the close of the market. Biomerica share today touched a day high of $2.64 and a low of $2.18.

What is the 52 week high and 52 week low for Biomerica share?

Biomerica share touched a 52 week high of $3.21 on and a 52 week low of $1.45 on . Biomerica stock price today i.e. is closed at $2.32,which is 27.80% down from its 52 week high and 60.00% up from its 52 week low.

What is Biomerica's market capitalisation today?

Biomerica market capitalisation is $0.00T as on .

How to invest in Biomerica Stock (BMRA) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Biomerica on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Biomerica Shares that will get you 0.6466 shares as per Biomerica share price of $2.32 per share as on September 26, 2026 at 8:46 am IST.

What is the minimum amount required to buy Biomerica Stock (BMRA) from India?

Indian investors can start investing in Biomerica (BMRA) shares with as little as ₹95.819999694824 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹958.20 in Biomerica stock (as per the Rupee-Dollar exchange rate as on ). Based on Biomerica share’s latest price of $2.32 as on September 26, 2026 at 8:46 am IST, you will get 4.3103 shares of Biomerica. Learn more about fractional shares .

What are the returns that Biomerica has given to Indian investors in the last 5 years?

Biomerica stock has given -94.35% share price returns and 29.7% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?